## HPV Types and Cervical Carcinoma Risk **Key Point:** HPV type 16 is responsible for approximately 50–55% of all cervical squamous cell carcinomas globally, making it the single most oncogenic HPV type. ### HPV Classification by Oncogenic Potential | HPV Type | Oncogenic Risk | Associated Cancers | Prevalence in SCC | |----------|----------------|-------------------|-------------------| | 16 | High (α-9) | Cervical SCC, oropharyngeal | 50–55% | | 18 | High (α-7) | Cervical adenocarcinoma, SCC | 15–20% | | 31 | High (α-9) | Cervical SCC | 3–5% | | 33 | High (α-9) | Cervical SCC | 3–5% | | 6, 11 | Low | Benign warts, RRP | <1% in SCC | **High-Yield:** HPV 16 and 18 together account for approximately 70% of cervical cancers. HPV 16 is associated with squamous cell carcinoma, while HPV 18 has a higher association with adenocarcinoma of the cervix. ### Mechanism of Oncogenesis HPV 16 encodes two critical viral oncoproteins: 1. **E6 protein** — inactivates p53 tumor suppressor, preventing apoptosis 2. **E7 protein** — inactivates retinoblastoma (Rb) protein, disrupting G1/S checkpoint These dual mechanisms make HPV 16 uniquely aggressive and account for its high prevalence in invasive cervical cancers. **Clinical Pearl:** Persistent infection with HPV 16 (lasting >12 months) carries a 30–40% risk of progression to cervical intraepithelial neoplasia (CIN) grade 2 or 3, compared to <5% for low-risk types. **Mnemonic:** **"16 is the WORST"** — HPV 16 is the most common and most oncogenic type, responsible for the majority of cervical squamous cell carcinomas and many oropharyngeal cancers. [cite:Robbins 10e Ch 22]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.